tiprankstipranks
Trending News
More News >
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
US Market

Coya Therapeutics, Inc. (COYA) Income Statement

Compare
111 Followers

Coya Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Coya Therapeutics, Inc.'s total revenue was $3.96M, an increase of 202768.80% from the same quarter last year. In Q4, Coya Therapeutics, Inc.'s net income was $-5.71M. See Coya Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.95M$ 3.55M$ 6.00M$ 0.00$ 0.00
Gross Profit
$ 7.92M$ -8.31M$ 500.68K$ -4.41M$ 0.00
Operating Expenses
$ 28.18M$ 8.94M$ 8.40M$ 5.40M$ 4.87M
Depreciation and Amortization
$ 27.36K$ 27.36K$ 27.36K$ 27.36K$ 16.13K
EBITDA
$ -20.24M$ -17.20M$ -7.33M$ -9.26M$ -4.85M
Operating Income
$ -20.27M$ -17.25M$ -7.90M$ -9.81M$ -4.87M
Other Income/Expenses
$ -957.39K$ 1.65M$ 639.37K$ -2.43M$ -21.48K
Pretax Income
$ -21.22M$ -15.60M$ -7.26M$ -12.24M$ -4.89M
Net Income
$ -21.23M$ -14.88M$ -7.99M$ -12.24M$ -4.89M
Per Share Metrics
Basic EPS
$ -1.27$ -0.98$ -0.79$ -1.23$ -0.74
Diluted EPS
$ -1.27$ -0.98$ -0.79$ -1.23$ -0.74
Weighted Average Shares Outstanding
16.73M 15.24M 10.16M 9.95M 6.60M
Weighted Average Shares Outstanding (Diluted)
16.73M 15.24M 10.16M 9.95M 6.60M
Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History